Screener
Sionna Therapeutics SION Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Operating lease liability, noncurrent | 7,055 | 7,408 |
| Total liabilities | 16,831 | 19,120 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value, 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 45,075,651 and 44,723,585 shares issued, 45,075,651 and 44,723,585 shares outstanding as of March 31, 2026 and December 31, 2025, respectively | 45 | 45 |
| Additional paid-in capital | 571,380 | 562,602 |
| Accumulated other comprehensive (loss) income | (84) | 540 |
| Accumulated deficit | (283,133) | (256,354) |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's preferred stock, shares authorized?
- Sionna Therapeutics (SION) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Sionna Therapeutics's preferred stock, shares authorized changed year-over-year?
- Sionna Therapeutics's preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
Ask your AI about Sionna Therapeutics's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude